Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
MEMSID: Results From a Phase 2 Pilot Study on Memantine Treatment for Sickle Cell Disease.
Hemasphere. 2020 Aug 11;4(4):e452. doi: 10.1097/HS9.0000000000000452. eCollection 2020 Aug.
Hemasphere. 2020.
PMID: 32885144
Free PMC article.
No abstract available.
A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment.
Mahkro A, Hegemann I, Seiler E, Simionato G, Claveria V, Bogdanov N, Sasselli C, Torgerson P, Kaestner L, Manz MG, Goede JS, Gassmann M, Bogdanova A.
Mahkro A, et al. Among authors: sasselli c.
EJHaem. 2020 May 20;1(1):23-34. doi: 10.1002/jha2.11. eCollection 2020 Jul.
EJHaem. 2020.
PMID: 35847705
Free PMC article.
Item in Clipboard
Cite
Cite